By prioritising community engagement, enabling remote enrollment, and clearly communicating risks and benefits, researchers and sponsors can help create safer, more inclusive clinical trials for pregnant individuals. Exp...
Press releases
-
ICON acquisition creates world-leading healthcare intelligence and clinical research organisation
The combined company will leverage its enhanced operations to transform clinical trials and accelerate biopharma customer’s commercial success through the development of medicines and medical devices.
-
ICON shareholders vote in favour of all resolutions at its Extraordinary General Meeting
All resolutions at the ICON Extraordinary General Meeting held on June 15, 2021 (which resolutions had all been recommended by the Board) were all duly passed by shareholders. -
ICON reports first quarter 2021 results
Record net business wins in the quarter of $1,100 million, an increase of 27% year on year; a net book to bill of 1.28.
-
ICON wins multiple categories in 2021 CRO Leadership Awards for the fourth year in a row
ICON received 2021 CRO Leadership Awards. ICON achieved awards in both the Big Pharma and Overall groups.
-
ICON reports fourth quarter and full year 2020 results
Record net business wins in the quarter of $1,080 million; a book to bill of 1.42. Full year net business wins of $3.8 billion; a net book to bill of 1.38.
-
ICON to acquire PRA Health Sciences
Creating a world leader in Healthcare Intelligence and Clinical Research.
-
ICON launches FIRECREST Safety Letters and Site Question Management
ICON launches FIRECREST Safety Letters and Site Question Management supporting regulatory compliance and increasing site support.
-
ICON supports Pfizer and BioNTech on the investigational COVID-19 vaccine trial
ICON provided both decentralised and on-site clinical trial services to the Pfizer BioNTech COVID-19 vaccine programme. -
ICON releases first environmental, social and governance report
ICON announces the release of its first Environmental, Social and Governance (ESG) Report.
-
ICON reports third quarter 2020 results
Quarter 3 reported revenue of $701.7 million representing a year on year decrease of 1.2% and 13.1% increase on Quarter 2 2020.
